Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 262, pseudogene (RN7SL262P)

Target
RN7SL262P
Molecular classification
Pseudogene, Noncoding RNA, Miscellaneous RNA
01

Overview

RN7SL262P (RNA, 7SL, cytoplasmic 262, pseudogene) is a human genomic locus classified as a pseudogene related to the functional 7SL RNA that forms part of the signal recognition particle (SRP) complex necessary for protein targeting to membranes[1][4][7]. In humans, numerous 7SL RNA-related pseudogenes exist throughout the genome, the result of reverse transcription and integration events but generally lacking protein-coding capacity or clear biological activity[4][7]. Functional 7SL RNA is crucial for SRP activity, but RN7SL262P is a truncated, likely non-functional derivative. Some pseudogene transcripts participate in cellular regulation through competing for microRNA binding or, less commonly, generating regulatory small RNAs, but no specific function or disease linkage has been established for RN7SL262P itself[5][8]. RN7SL262P is not considered a therapeutic target, biomarker, or safety risk in clinical practice.

Other names
RN7SL262PRNA, 7SL, cytoplasmic 262, pseudogene7SL pseudogene
02

Mechanism of action

Not applicable; no drugs target RN7SL262P specifically

03

Biological functions

No known direct function for RN7SL262P itself is established in literatureMicroRNA decoy (general pseudogenes)Source of small interfering RNAs (general pseudogenes)
04

Disease associations

No specific evidence links RN7SL262P directly to any concrete disease roleImplicated in cancer (general pseudogenes)Regulation of tumor suppressors (general pseudogenes)
05

Safety considerations

None
06

Interacting drugs

None
07

Biomarkers

None

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 262, pseudogene (RN7SL262P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 262, pseudogene (RN7SL262P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call